These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1612330

  • 1. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis.
    Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ.
    Gastroenterology; 1992 Jul; 103(1):229-34. PubMed ID: 1612330
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
    Hsia HC, Lin HC, Lee FY, Tsai YT, Lee SD, Meng HC, Chao Y, Wang SS, Lo KJ.
    J Gastroenterol Hepatol; 1993 Jul; 8(1):15-20. PubMed ID: 8094983
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis.
    Lin HC, Hou MC, Lee WC, Huang YT, Lee FY, Chang FY, Tsai YT, Lee SD.
    Am J Gastroenterol; 1999 Apr; 94(4):1012-7. PubMed ID: 10201475
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
    McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, McIntyre N, Burroughs AK.
    Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
    [Abstract] [Full Text] [Related]

  • 7. Octreotide decreased liver metabolic activity in patients with hepatitis B surface antigen-positive cirrhosis.
    Lin HC, Tsai YT, Lee SD, Lee FY, Hsia HC, Meng HC, Wang SS, Lo KJ.
    Clin Pharmacol Ther; 1992 Aug; 52(2):134-8. PubMed ID: 1354573
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
    Ottesen LH, Flyvbjerg A, Møller S, Bendtsen F.
    Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
    [Abstract] [Full Text] [Related]

  • 10. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
    Møller S, Brinch K, Henriksen JH, Becker U.
    J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
    Jenkins SA, Nott DM, Baxter JN.
    HPB Surg; 1998 May; 11(1):13-21. PubMed ID: 9830576
    [Abstract] [Full Text] [Related]

  • 13. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
    Kurokawa H, Sekiyama T, Katsuta Y, Aramaki T.
    Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
    [Abstract] [Full Text] [Related]

  • 14. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J, Kravetz D, Rodes J.
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of octreotide on total effective vascular compliance in patients with posthepatitic cirrhosis.
    Lin HC, Tsai YT, Yang MC, Lee FY, Hou MC, Chen LS, Lee SD.
    J Hepatol; 1996 Jan; 24(1):81-7. PubMed ID: 8834029
    [Abstract] [Full Text] [Related]

  • 17. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
    Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, Lee SD, Lo KJ.
    J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
    [Abstract] [Full Text] [Related]

  • 18. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ.
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
    Lee FY, Tsai YT, Lin HC, Lee SD, Hsia HC, Lin WJ, Wang SS, Lai KH, Lo KJ.
    J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656
    [Abstract] [Full Text] [Related]

  • 20. Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study.
    Zironi G, Rossi C, Siringo S, Galaverni C, Gaiani S, Piscaglia F, Bolondi L.
    Liver; 1996 Aug; 16(4):225-34. PubMed ID: 8877991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.